Device / Technology News

RSS

BioCentric Energy to grow algae strain with high EPA/DHA oil content in V3 Algae-Pro systems

BioCentric Energy is pleased to announce that the final engineering on the V3 Algae-Pro Photobioreactor system is now complete. We have received via shipment from China the 32 Corners for the V3 Alga-Pro system. Also received at the Santa Ana headquarters are the 8,000 lineal feet of proprietary, seven layer tubing. Installation of the V3 Algae-Pro system will commence over the next two weeks.

29 Jan 2010

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

ChromoCure, Inc. -- The Company announced today, based on the recent validation of its cancer detection approach and efficacy of its proprietary Chromosomal Scanning Technology, that it has retained Patent & Intellectual Property Attorneys to assess its growing Intellectual Property portfolio and secure necessary filings and Patent protections.

29 Jan 2010

Should medical workers participate in the development of "medicalized" weapons?

(Garrison, NY) The latest issue of the Hastings Center Report features articles on "medicalized" weapons that temporarily incapacitate targets, sharing the benefits of newly found biological resources, and applications of GINA (the Genetic Information Nondisclosure Act).

29 Jan 2010

Hitachi High-Technologies to begin shipment of Tabletop Microscope TM3000 from April

Hitachi High-Technologies Corporation today announced the development of the Tabletop Microscope TM3000. Shipments of the compact, affordably priced, and exceptionally user-friendly TM3000 are scheduled to start on April 1, 2010.

29 Jan 2010

New XtraCredit application provides physicians with CME credit for online clinical research

Wolters Kluwer Health, a leading provider of medical information, has launched XtraCredit®, an iPhone® and iPod Touch® application that provides physicians with continuing medical education (CME) credit for clinical research done online.

29 Jan 2010

Researchers use sophisticated brain-imaging techniques to predict Alzheimer's before symptoms appear

Estimates are that some 10 percent of people over the age of 65 will develop Alzheimer's disease, the scourge that robs people of their memories and, ultimately, their lives.

29 Jan 2010

UCLA researchers predict brain's progression to Alzheimer's before symptoms are visible

Estimates are that some 10 percent of people over the age of 65 will develop Alzheimer's disease, the scourge that robs people of their memories and, ultimately, their lives.

29 Jan 2010

Invatec welcomes first clinical results of Drug Eluting Balloon

Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirion, for complex Critical Limb Ischemia (CLI) in Below the Knee (BtK).

29 Jan 2010

Targeted sequencing of exome can help identify potential disease-causing genes

Researchers from University of Miami Miller School of Medicine and Roche Applied Science have recently published a research study on human exome resequencing results from eight individuals that span across three generations of a family. The findings of this study showcased the value of targeted enrichment for family-based studies which allows researchers to quickly identify potential disease-causing genetic variants and will provide the data and information for further research to better understand disease and the impact across generations of a family.

29 Jan 2010

UCLA's non-invasive pre-surgical testing approach leads to seizure-free surgical outcome in TSC patients

When medication fails to control seizures in children with tuberous sclerosis complex (TSC), a rare genetic disorder that affects multiple organ systems and frequently causes epilepsy, surgery to remove part of the brain is often necessary. But pre-surgical testing, which involves the implanting of electrodes into a child's head, can lead to longer hospital stays and greater risks from surgery.

29 Jan 2010

ECRI Institute publishes Health Devices guidance article for hospitals

Electronic health records (EHRs) are the future of medical record keeping. The American Recovery and Reinvestment Act (ARRA) includes incentive payments for hospitals that adopt an EHR, but the timetable for implementation is especially tight.

29 Jan 2010

Methodology and evidence behind national mammography guidelines is questionable, says JDMS review

The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a review in the Journal of Diagnostic Medical Sonography (JDMS), published by SAGE.

29 Jan 2010

UT-Battelle exclusively licenses patents on inventions based on Nell-1 gene

In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle announced at a signing ceremony here today that it has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of research performed at the Department of Energy laboratory.

29 Jan 2010

Vangard announces partnership with Vista LifeSciences to voice-enable medical record products

Vangard Voice Systems, Inc. (Vangard), the innovative provider of the AccuSpeech® Mobile Voice Platform (MVP) which adds high productivity voice-direct capabilities to existing mobile applications, announced a partnership with Vista LifeSciences to voice-enable Vista LifeSciences' medical assessment and clinical encounter/medical record products.

29 Jan 2010

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.

29 Jan 2010

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA). The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.

29 Jan 2010

Merge Healthcare deploys etrials eDiary 5.0 platform for global urology clinical trial

Merge Healthcare has successfully deployed its etrials eDiary 5.0 platform to conduct a global Phase II urology clinical trial involving 750 patients for one of the largest pharmaceutical companies in the world. Merge was awarded the project because of its eDiary technology, experience in global ePRO (electronic patient reported outcomes) trials and ability to manage the complex logic required by this study. Underway in 22 countries on 3 continents and in 34 languages, the trial also utilizes Merge’s new eDiary Inventory Module to track shipping and supply of study devices in real-time.

29 Jan 2010

Ultra–X BH selected as exclusive distributor for CTLM system in Brazil

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that Ultra–X BH has been selected as the exclusive distributor for the CT Laser Mammography (CTLM®) system throughout Brazil. The company will market the system to the private and public sector.

29 Jan 2010

Suture Express sold to Diamond Castle Partners

Code Hennessy & Simmons LLC ("CHS") announced the sale of Suture Express, Inc., a portfolio investment of CHS Private Equity V LP and Linden LLC, to Diamond Castle Partners, a New York-based private equity firm.

29 Jan 2010

AMP releases new position statement on the oversight of LDTs

Today, the Association for Molecular Pathology (AMP) released its new position statement on the oversight of laboratory developed tests (LDTs), a recent focus of debate among policy makers, the laboratory community and other stakeholders.

29 Jan 2010

Device / Technology News

BioCentric Energy to grow algae strain with high EPA/DHA oil content in V3 Algae-Pro systems

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

Should medical workers participate in the development of "medicalized" weapons?

Hitachi High-Technologies to begin shipment of Tabletop Microscope TM3000 from April

New XtraCredit application provides physicians with CME credit for online clinical research

Researchers use sophisticated brain-imaging techniques to predict Alzheimer's before symptoms appear

UCLA researchers predict brain's progression to Alzheimer's before symptoms are visible

Invatec welcomes first clinical results of Drug Eluting Balloon

Targeted sequencing of exome can help identify potential disease-causing genes

UCLA's non-invasive pre-surgical testing approach leads to seizure-free surgical outcome in TSC patients

ECRI Institute publishes Health Devices guidance article for hospitals

Methodology and evidence behind national mammography guidelines is questionable, says JDMS review

UT-Battelle exclusively licenses patents on inventions based on Nell-1 gene

Vangard announces partnership with Vista LifeSciences to voice-enable medical record products

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

Merge Healthcare deploys etrials eDiary 5.0 platform for global urology clinical trial

Ultra–X BH selected as exclusive distributor for CTLM system in Brazil

Suture Express sold to Diamond Castle Partners

AMP releases new position statement on the oversight of LDTs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News